136 related articles for article (PubMed ID: 9007982)
1. Recombinant hirustasin: production in yeast, crystallization, and interaction with serine proteases.
Di Marco S; Fendrich G; Knecht R; Strauss A; Pohlig G; Heim J; Priestle JP; Sommerhoff CP; Grütter MG
Protein Sci; 1997 Jan; 6(1):109-18. PubMed ID: 9007982
[TBL] [Abstract][Full Text] [Related]
2. A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex.
Mittl PR; Di Marco S; Fendrich G; Pohlig G; Heim J; Sommerhoff C; Fritz H; Priestle JP; Grütter MG
Structure; 1997 Feb; 5(2):253-64. PubMed ID: 9032072
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis.
Söllner C; Mentele R; Eckerskorn C; Fritz H; Sommerhoff CP
Eur J Biochem; 1994 Feb; 219(3):937-43. PubMed ID: 8112345
[TBL] [Abstract][Full Text] [Related]
4. Bdellastasin, a serine protease inhibitor of the antistasin family from the medical leech (Hirudo medicinalis)--primary structure, expression in yeast, and characterisation of native and recombinant inhibitor.
Moser M; Auerswald E; Mentele R; Eckerskorn C; Fritz H; Fink E
Eur J Biochem; 1998 Apr; 253(1):212-20. PubMed ID: 9578479
[TBL] [Abstract][Full Text] [Related]
5. Interaction of recombinant CanPIs with Helicoverpa armigera gut proteases reveals their processing patterns, stability and efficiency.
Mishra M; Tamhane VA; Khandelwal N; Kulkarni MJ; Gupta VS; Giri AP
Proteomics; 2010 Aug; 10(15):2845-57. PubMed ID: 20517884
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
Katz BA; Liu B; Barnes M; Springman EB
Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
[TBL] [Abstract][Full Text] [Related]
7. Amino acid sequence of piguamerin, an antistasin-type protease inhibitor from the blood sucking leech Hirudo nipponia.
Kim DR; Kang KW
Eur J Biochem; 1998 Jun; 254(3):692-7. PubMed ID: 9688284
[TBL] [Abstract][Full Text] [Related]
8. Controlled proteolysis of amelogenins reveals exposure of both carboxy- and amino-terminal regions.
Moradian-Oldak J; Jimenez I; Maltby D; Fincham AG
Biopolymers; 2001 Jun; 58(7):606-16. PubMed ID: 11285557
[TBL] [Abstract][Full Text] [Related]
9. Expression of a kallikrein-like protease from the snake venom: engineering of autocatalytic site in the fusion protein to facilitate protein refolding.
Hung CC; Chiou SH
Biochem Biophys Res Commun; 2000 Sep; 275(3):924-30. PubMed ID: 10973823
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of recombinant guamerin, an elastase-specific inhibitor, in the methylotrophic yeast Pichia pastoris.
Kim KY; Lim HK; Lee KJ; Park DH; Kang KW; Chung SI; Jung KH
Protein Expr Purif; 2000 Oct; 20(1):1-9. PubMed ID: 11035944
[TBL] [Abstract][Full Text] [Related]
11. An SRLLR motif downstream of the scissile bond enhances enterokinase cleavage efficiency.
Liew OW; Jenny Chong PC; Lim YZ; Ang CX; Amy Lau YC; Yandle TG; Brennan SO
Biochimie; 2007 Jan; 89(1):21-9. PubMed ID: 17097793
[TBL] [Abstract][Full Text] [Related]
12. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.
Aulak KS; Davis AE; Donaldson VH; Harrison RA
Protein Sci; 1993 May; 2(5):727-32. PubMed ID: 8495195
[TBL] [Abstract][Full Text] [Related]
13. Redesigning the reactive site loop of the wheat subtilisin/chymotrypsin inhibitor (WSCI) by site-directed mutagenesis. A protein-protein interaction study by affinity chromatography and molecular modeling.
Bruni N; Di Maro A; Costantini S; Chambery A; Facchiano AM; Ficca AG; Parente A; Poerio E
Biochimie; 2009 Sep; 91(9):1112-22. PubMed ID: 19500644
[TBL] [Abstract][Full Text] [Related]
14. BIP co-chaperone MTJ1/ERDJ1 interacts with inter-alpha-trypsin inhibitor heavy chain 4.
Kroczynska B; King-Simmons L; Alloza L; Alava MA; Elguindi EC; Blond SY
Biochem Biophys Res Commun; 2005 Dec; 338(3):1467-77. PubMed ID: 16271702
[TBL] [Abstract][Full Text] [Related]
15. Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system.
Rester U; Bode W; Moser M; Parry MA; Huber R; Auerswald E
J Mol Biol; 1999 Oct; 293(1):93-106. PubMed ID: 10512718
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prostaglandin H synthase isoform structures using limited proteolytic digestion.
Guo Q; Chang S; Diekman L; Xiao G; Kulmacz RJ
Arch Biochem Biophys; 1997 Aug; 344(1):150-8. PubMed ID: 9244392
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.
Agbuya PG; Sherman NE; Moen LK
Arch Biochem Biophys; 2001 Aug; 392(1):93-102. PubMed ID: 11469799
[TBL] [Abstract][Full Text] [Related]
18. The 1.2 A crystal structure of hirustasin reveals the intrinsic flexibility of a family of highly disulphide-bridged inhibitors.
Usón I; Sheldrick GM; de La Fortelle E; Bricogne G; Di Marco S; Priestle JP; Grütter MG; Mittl PR
Structure; 1999 Jan; 7(1):55-63. PubMed ID: 10368273
[TBL] [Abstract][Full Text] [Related]
19. Two reactive site locations and structure-function study of the arrowhead proteinase inhibitors, A and B, using mutagenesis.
Xie ZW; Luo MJ; Xu WF; Chi CW
Biochemistry; 1997 May; 36(19):5846-52. PubMed ID: 9153425
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
